Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bertino

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancerDwight H Owen, Terence M Williams, Erin M Bertino, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNAThomas E Stinchcombe, Xiaofei Wang, Robert C Doebele, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2023
Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancyErin M Bertino, Madison M Grogan, Jason A Benedict, et al.
Clinical Lung Cancer|July 1, 2015
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC PatientsErin M Bertino, Terence M Williams, S Patrick Nana-Sinkam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2018
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung CancerEric D Miller, James L Fisher, Karl E Haglund, et al.
Radiation Oncology (London, England)|October 7, 2018
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer databaseEric D Miller, James L Fisher, Karl E Haglund, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2019
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancersMingjia Li, Daniel Spakowicz, Jarred Burkart, et al.
JAMA Oncology|August 9, 2019
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialThomas E Stinchcombe, Pasi A Jänne, Xiaofei Wang, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancerDwight H Owen, Terence M Williams, Erin M Bertino, et al.
Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNAThomas E Stinchcombe, Xiaofei Wang, Robert C Doebele, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2023
Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancyErin M Bertino, Madison M Grogan, Jason A Benedict, et al.
Clinical Lung Cancer|July 1, 2015
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC PatientsErin M Bertino, Terence M Williams, S Patrick Nana-Sinkam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2018
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung CancerEric D Miller, James L Fisher, Karl E Haglund, et al.
Radiation Oncology (London, England)|October 7, 2018
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer databaseEric D Miller, James L Fisher, Karl E Haglund, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2019
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancersMingjia Li, Daniel Spakowicz, Jarred Burkart, et al.
JAMA Oncology|August 9, 2019
Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialThomas E Stinchcombe, Pasi A Jänne, Xiaofei Wang, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Pageof 7